Education
From 1/10/2015 Università degli studi di Milano
PhD student in Pharmacological Sciences in the Laboratory of Lipoproteins and Atherosclerosis, directed by Prof. Alberico L. Catapano, at the Department of Pharmacological and Biomolecular Sciences.
10/2017-2/2014 Università degli studi di Milano
Master student of Pharmaeutical Biotechnology - Università degli Studi di Milano - Bachelor’s degree student of Pharmaceutical Biotechnology
Research and accademicexperience
4/2013-2/2014 William Harvey Research Institute - Fellowship in the Laboratory directed by Professor F. Marelli-Berg
Università degli studi di Milano - Internship in the Laboratory of Lipoproteins and Atherosclerosis, directed by Prof. Alberico L. Catapano, at the Department of Pharmacological and Biomolecular Sciences
Università degli Studi di Milano - Internship in the Laboratory of Lipoproteins and Atherosclerosis, directed by Prof. Alberico L. Catapano, at the Department of Pharmacological and Biomolecular Sciences
Major achievements
- 2017, EAS Congress; 23-26 April; Prague, Czech Republic. Poster titled: “LDLR influence on CD4 T Cell differetiation in mice and in Familial Hypercholesterolemia patients”
- 2016, Participant to the iARS (International Atherosclerosis Research School); 21-27 august; Hamburg, Germany.
- 2016, Next step7; 11th July, Milan, Itlay. Oral presentation titled: “Pentraxin 3 plays a key role in the immunomodulation of diet induced-obesity in mice”
- 2016, EAS Congress; 29 May-1 June; Innsbruck, Austria. E-poster titled: “Pentraxin 3 plays a key role in the immunomodulation of diet induced-obesity in mice”
-2016, Participant to the EAS advanced course on AIL (Atherosclerosis-Immunology-Lipids); 22 March-25 March; Trippenhuis, Amsterdam, The Netherlands.
- 2015, 29° SISA National Congress; 22-24 November, Bologna, Italy
Poster titled: “PENTRAXIN 3 PLAYS A KEY ROLE IN THE IMMUNOMODULATION OF DIET INDUCED-OBESITY IN MICE”
- 2015 SISA Lombardia Congress; 16-17 October, Milan, Italy.
Oral presentation titled: “LA PENTRAXINA LUNGA 3 (PTX3) SVOLGE UN RUOLO CHIAVE NELL’IMMUNOMODULAZIONE DELL’OBESITÀ INDOTTA DA DIETA AD ALTO CONTENUTO DI GRASSI NEL TOPO”
Professional memberships
- From 2015, Member of EAS (European Atherosclerosis Society)
- From 2015, Member of SISA (Società Italiana per lo Studio dell’Ateroscleros
Bonacina F, Moregola A, Porte R, Baragetti A, Bonavita E, Salatin A, Grigore L, Pellegatta F, Molgora M, Sironi M, Barbati E, Mantovani A, Bottazzi B, Catapano AL, Garlanda C, Norata GD
Cardiovasc Res. 2019 Mar 12. pii: 5374872.